A reservoir of stem-like CD8 T cells in the tumor-draining lymph node maintains the ongoing anti-tumor immune response

Kelli A. Connolly, Manik Kuchroo, Aarthi Venkat, Achia Khatun, Jiawei Wang, Ivana William, Noah I. Hornick, Brittany Fitzgerald, Martina Damo, Moujtaba Y. Kasmani, Can Cui, Eric Fagerberg, Isabel Monroy, Amanda Hutchins, Julie F. Cheung, Gena G. Foster, Dylan L. Mariuzza, Hongyu Zhao, Weiguo Cui, Smita Krishnaswamy, Nikhil S. JoshibioRxiv 2021 · DOI

TL;DR

This paper reveals that a crucial reservoir of "stem-like" CD8 T cells resides in the tumor-draining lymph nodes (dLNs), not within the tumor itself. These dLN T cells are essential for sustaining the anti-tumor immune response by migrating into the tumor and preventing premature differentiation and exhaustion of effector T cells.

What Problem Does This Paper Address?

The efficacy of immunotherapy, particularly checkpoint inhibitors, relies on the sustained activity of CD8 T cells against tumors. A key subset of these T cells, known as "stem-like" TCF1+ CD8+ T cells (TSL), are critical for long-term anti-tumor immunity. However, the tumor microenvironment (TME) is known to promote T cell differentiation and exhaustion. This raises a fundamental question: how are these crucial TSL cells maintained and how do they sustain the anti-tumor response within the challenging TME? The authors investigate the location and maintenance mechanisms of these TSL cells, hypothesizing that they might be sustained in a niche outside the direct influence of the TME.

Methods

The study employed a multi-pronged approach combining advanced techniques:

  • Autochthonous Mouse Model: They utilized a genetically engineered mouse model (KP-NINJA) that spontaneously develops lung adenocarcinoma, allowing for the study of tumor development and immune responses in a more naturalistic setting.
  • Single-Cell RNA Sequencing (scRNA-seq) and TCR Sequencing: This powerful combination allowed for the deep characterization of individual T cells, identifying distinct cell populations, their gene expression profiles, and their clonal relationships.
  • Flow Cytometry and Immunohistochemistry (IHC): These standard techniques were used to quantify T cell populations, assess protein expression (e.g., TCF1, PD-1, Tim-3, SLAMF6), and visualize T cell infiltration in tumor tissues.
  • PHATE and scVelo: These computational tools were used to visualize complex single-cell data, infer developmental trajectories, and understand the dynamics of T cell differentiation.
  • Lymphocyte Migration Blocking: The drug FTY720 was used to block lymphocyte migration, allowing the researchers to test the hypothesis that dLN T cells migrate into tumors.

Datasets

The study primarily used data generated from their own experiments using the KP-NINJA mouse model. They also analyzed a publicly available single-cell RNA sequencing dataset from human lung adenocarcinoma patients (GSE131907) to assess the relevance of their findings in human disease.

Key Insights and Ideas

  • dLN as a TSL Reservoir: The most striking finding is the identification of tumor-draining lymph nodes (dLNs) as the primary reservoir for "stem-like" TCF1+ CD8+ T cells (TSL). These cells are transcriptionally and phenotypically similar to TSL cells found during chronic viral infections.
  • dLN TSL Cells are Precursors: These dLN TSL cells are the developmental precursors to the more differentiated, effector T cells found within the tumor.
  • Migration is Key for TSL Maintenance: The maintenance of TCF1 expression (a hallmark of TSL cells) in intratumoral T cells is dependent on continuous migration from the dLN. Blocking this migration significantly reduces TSL cells in the tumor.
  • TME Drives Differentiation, dLN Protects: While the tumor microenvironment drives T cell differentiation towards an exhausted state, the dLN environment appears to preserve the stem-like characteristics of TSL cells.
  • Human Relevance: The presence of TSL-like populations in lymph nodes of lung cancer patients suggests that this mechanism is conserved and relevant in human disease.

Key Results

  • Tumor vs. dLN TSL: While tumors contained a small number of TCF1+ CD8+ T cells that differentiated over time, the dLNs maintained a stable, abundant population of TCF1+ PD-1+ CD8+ T cells with TSL-like gene expression signatures.
  • Migration Blockade Impact: Blocking lymphocyte migration with FTY720 led to a significant ~4-fold drop in TCF1+ CD8+ T cells within tumors, while dLN TCF1+ CD8+ T cell numbers remained unaffected.
  • Human LUAD Data: Analysis of human lung adenocarcinoma data revealed TSL-like populations predominantly in non-metastatic lymph nodes, supporting the dLN reservoir hypothesis.
  • Transcriptional Similarity: Tumor-specific TSL cells in dLNs showed closer gene expression similarity to TSL cells from chronic LCMV infection than to TSL cells found within tumors.

Limitations and Future Work

  • Mechanism of dLN Migration: While the study demonstrates the necessity of migration from dLNs for TSL maintenance, the specific signals that drive this migration remain unclear. Future work could explore the role of chemokines and other signaling molecules.
  • Role of DCs: The role of dendritic cells (DCs) in maintaining TSL cells within dLNs is uncertain and warrants further investigation.
  • Therapeutic Implications for Cold Tumors: The findings suggest that strategies aimed at enhancing TSL cell function or promoting their migration into tumors could be beneficial for treating "cold" tumors, which are poorly infiltrated by T cells and respond poorly to immunotherapy. The study hints at potential therapeutic targets beyond PD-1, such as co-stimulatory receptors.

Summary updated

Abstract

Abstract “Stem-like” TCF1 + CD8 + T cells (T SL ) are necessary for long-term maintenance of T cell responses and the efficacy of immunotherapy but, as tumors contain signals that should drive T-cell terminal-differentiation, how these cells are maintained in tumors remains unclear. We found that a small number of TCF1 + tumor-specific CD8 + T cells were present in tumors throughout development. Yet, most intratumoral T cells differentiated as tumors progressed, corresponding with an immunologic shift in the tumor microenvironment (TME) from “hot” to “cold”. By contrast, most tumor-specific CD8 + T cells in tumor-draining lymph nodes (dLNs) had functions and gene expression signatures similar to T SL from chronic LCMV infection and this population was stable over time, despite the changes in the TME. dLN T cells were the precursors of their more-differentiated intratumoral counterparts, and maintenance of TCF1 by intratumoral T cells required continuous migration from dLNs. Finally, T SL CD8 T cells were also present in LNs from lung adenocarcinoma patients, suggesting this population is also relevant in human disease. Thus, we propose that the dLN T SL reservoir has a critical function during tumor development in sustaining antitumor T cells during tumor development and protecting them from the terminal differentiation that occurs in the TME.
BibTeX
@misc{connolly2021reservoir,
  author = {Kelli A. Connolly and Manik Kuchroo and Aarthi Venkat and Achia Khatun and Jiawei Wang and Ivana William and Noah I. Hornick and Brittany Fitzgerald and Martina Damo and Moujtaba Y. Kasmani and Can Cui and Eric Fagerberg and Isabel Monroy and Amanda Hutchins and Julie F. Cheung and Gena G. Foster and Dylan L. Mariuzza and Hongyu Zhao and Weiguo Cui and Smita Krishnaswamy and Nikhil S. Joshi},
  title = {{A reservoir of stem-like CD8 T cells in the tumor-draining lymph node maintains the ongoing anti-tumor immune response}},
  year = {2021},
  doi = {10.1101/2021.01.27.428467},
  howpublished = {bioRxiv},
}
Figure